Full Paper
T.-S. Tang, I. Bezprozvanny, D. E. Frantz, J. Hsieh, Nat. Chem. Biol. 2008,
, 408–410.
6] For 3-carbamoylisoxazoles, see: a) W. Tuo, N. Leleu-Chavain, A. Barczyk,
[17] For a recent example utilizing other starting materials, see: J. S. Oakdale,
R. K. Sit, V. V. Fokin, Chem. Eur. J. 2014, 20, 11101–11110.
[18] F. De Sarlo, F. Machetti, Condensation of Primary Nitro Compounds to
Isoxazole Derivatives: Stoichiometric to Catalytic, in: Methods and Applica-
tions of Cycloaddition Reactions in Organic Syntheses, Wiley, New York,
2014, p. 205–222.
[19] S. D. Nelson, D. J. Kasparian, W. F. Trager, J. Org. Chem. 1972, 37, 2686–
2688.
[20] E. Kaji, K. Harada, S. Zen, Chem. Pharm. Bull. 1978, 26, 3254–3256.
[21] K. Z. Harada, Chem. Pharm. Bull. 1980, 28, 3296–3303.
4
[
N. Renault, L. Lemaire, P. Chavatte, R. Millet, Bioorg. Med. Chem. Lett.
2016, 26, 2701–2705; b) P. A. Harris, B. W. King, D. Bandyopadhyay, S. B.
Berger, N. Campobasso, C. A. Capriotti, J. A. Cox, L. Dare, X. Dong, J. N.
Finger, L. C. Grady, S. J. Hoffman, J. U. Jeong, J. Kang, V. Kasparcova, A. S.
Lakdawala, R. Lehr, D. E. McNulty, R. Nagilla, M. T. Ouellette, C. S. Pao,
A. R. Rendina, M. C. Schaeffer, J. D. Summerfield, B. A. Swift, R. D. Totoritis,
P. Ward, A. Zhang, D. Zhang, R. W. Marquis, J. Bertin, P. J. Goughb, J. Med.
Chem. 2016, 59, 2163–2178; c) T. Meng, D. Zhang, Z. Xie, T. Yu, S. Wu, L.
Wyder, U. Regenass, K. Hilpert, M. Huang, M. Geng, J. Shen, J. Med. Chem.
[
22] Y. Basel, A. Hassner, Synthesis 1997, 309–312.
[
23] It has long been known that aliphatic and aromatic nitrile oxides dimer-
ize to furoxan, see: A. Werner, H. Buss, Ber. Dtsch. Chem. Ges. 1894, 27,
2
014, 57, 9832–9843.
7] For gaboxadol, see: a) P. Krogsgaard Larsen, Acta Chem. Scand. Sect. B
977, 31, 584–588; b) P. Krogsgaard Larsen, Nature 1977, 268, 53–55.
[
[
2
193–2201.
1
[
[
[
24] For the reversion of furoxans into nitrile oxides, see: D. R. Brittelli, G. A.
Boswell Jr., J. Org. Chem. 1981, 46, 316–320.
25] P. A. Wade, N. V. Amin, H.-K. Yen, D. T. Price, G. F. Huhn, J. Org. Chem.
8] For two specific best-selling drugs Leflunomide (Arava) and Sulpha-
methoxazole (Bactrim), see: M. Baumann, I. R. Baxendale, S. V. Ley, N.
Nikbin, Beilstein J. Org. Chem. 2011, 7, 442–495.
9] For Leflunomide (Arava) Sulphamethoxazole (Bactrim), see: a) G. Heu-
bach, G. Hoerlein, B. Sachse, Ger. Pat. DE2525023, 1975 [Chem. Abstr.
1
984, 49, 4595–4601.
26] T. Shimizu, Y. Hayashi, H. Shibafuchi, K. Teramura, Bull. Chem. Soc. Jpn.
986, 59, 2827–2831.
[
1
1
977, 86, 106569]; b) G. Bertolini, M. Aquino, M. Biffi, G. d'Atri, F. Di Pierro,
F. Ferrario, P. Mascagni, F. Somenzi, A. Zaliani, F. Leoni, J. Med. Chem.
997, 40, 2011–2016; c) A. Prakash, B. Jarvis, Drugs 1999, 58, 1137–1164.
[27] P. A. Harris, A. Jackson, J. A. Joule, Tetrahedron Lett. 1989, 30, 3193–3196.
[28] L. Cecchi, F. De Sarlo, F. Machetti, Eur. J. Org. Chem. 2006, 4852–4856.
[29] L. Guideri, F. De Sarlo, F. Machetti, Chem. Eur. J. 2013, 19, 665–677.
[30] F. Machetti, L. Cecchi, E. Trogu, F. De Sarlo, Eur. J. Org. Chem. 2007, 4352–
1
[
10] For isoxazolylpenicillins (Oxacillin), see: F. P. Doyle, A. A. W. Long, J. H. C.
Nayler, E. R. Stove, Nature 1961, 192, 1183–1184; F. P. Doyle, J. H. C.
Nayler, US2996501, 1961 [Chem. Abstr. 1962, 58, 31448]; for Flucloxacil-
lin, see: J. C. Hanson, A. A. W. Long, J. H. C. Nayler, E. R. Stove, J. Chem.
Soc. 1965, 5976–5983; for Dicloxacillin Cloxacillin, see: J. H. C. Nayler,
A. A. W. Long, D. M. Brown, P. Acred, G. N. Rolinson, F. R. Batchelor, S.
Stevens, R. Sutherland, Nature 1962, 195, 1264–1267; F. P. Doyle, J. H. C.
Nayler, Brit. Pat. GB905778, 1962 [Chem. Abstr. 1963, 58, 66517].
4
359.
[
31] Our synthetic procedure was repeated in other laboratories, see: a) Z.
Lian, S. D. Friis, T. Skrydstrup, Chem. Commun. 2015, 51, 3600–3603; b)
P. Das, A. O. Omollo, L. J. Sitole, E. McClendon, E. J. Valente, D. Raucher,
L. R. Walker, A. T. Hamme II, Tetrahedron Lett. 2015, 56, 1794–1797; c) G.
Shakya, H. Rivera Jr., D. J. Lee, M. J. Jaremko, J. J. La Clair, D. T. Fox, R. W.
Haushalter, A. J. Schaub, J. Bruegger, J. F. Barajas, A. R. White, P. Kaur,
E. R. Gwozdziowski, F. Wong, S.-C. Tsai, M. D. Burkart, J. Am. Chem. Soc.
[
11] For Zonisamide, see: a) H. Uno, M. Kurokawa, Chem. Pharm. Bull. 1978,
2
6, 3498–3503; b) H. Uno, M. Kurokawa, Y. Masuda, Ger. Offen.
2014, 136, 16792–16799; d) H. Mitsudera, K. Awasaguchi, T. Awano, K.
DE2825410, 1979 [Chem. Abs. 1980, 92, 128899]; c) H. Uno, M. Kuokawa,
Y. Masuda, H. Nishimara, J. Med. Chem. 1979, 22, 180–183.
Ujihara, WO2014119696, 2014 [Chem. Abstr. 2014, 161, 306272]; e) G.
Griffioen, T. Van Dooren, V. Rojas de La Palma, K. Shelley, A. Marchand,
S. Allasia, A. Kilonda, P. Chaltin, WO2010142801, 2010 [Chem. Abstr.
[
12] For Valdecoxib, see: a) J. J. Talley, D. L. Brown, J. S. Carter, M. J. Graneto,
C. M. Koboldt, J. L. Masferrer, W. E. Perkins, R. S. Rogers, A. F. Shaffer, Y. Y.
Zhang, B. S. Zweifel, K. Seibert, J. Med. Chem. 2000, 43, 775–777; b) J. J.
Talley, S. R. Bertenshaw, D. L. Brown, J. S. Carter, M. J. Graneto, M. S.
Kellogg, C. M. Koboldt, J. Yuan, Y. Y. Zhang, K. Seibert, J. Med. Chem.
2
011, 154, 64628]; f) G. Griffioen, T. Van Dooren, V. Rojas de La Palma,
K. Shelley, A. Marchand, S. Allasia, A. Kilonda, P. Chaltin, WO2010142801,
010 [Chem. Abstr. 2011, 154, 64628].
32] E. Trogu, C. Vinattieri, F. De Sarlo, F. Machetti, Chem. Eur. J. 2012, 18,
081–2093.
2
[
2
2
000, 43, 1661–1663; c) D. Ormrod, K. Wellington, A. J. Wagstaff, Drugs
002, 62, 2059–2071; d) I. Atukoralaa, D. J. Hunter, Expert Opin. Pharma-
2
[
[
33] J. Chau, S. Xu, M. A. Ciufolini, J. Org. Chem. 2013, 78, 11901–11910.
34] F. M. Cordero, D. Giomi, L. Lascialfari, Five-Membered Ring Systems with O
and N Atoms, in: Progress in Heterocyclic Chemistry (Eds.: G. W. Gribble,
J. A. Joule), Elsevier, Amsterdam, 2014, vol. 26, p. 319–348.
cother. 2013, 14, 1077–1086.
[
[
[
13] For Danazol, see: a) A. J. Manson, F. W. Stonner, H. C. Neumann, R. G.
Christiansen, R. L. Clarke, J. H. Ackerman, D. F. Page, J. W. Dean, D. K.
Phillips, G. O. Potts, A. Arnold, A. L. Beyler, R. O. Clinton, J. Med. Chem.
[35] M. P. Mower, D. G. Blackmond, J. Am. Chem. Soc. 2015, 137, 2386–2391.
[36] I. Yavari, M. Piltan, L. Moradi, Tetrahedron 2009, 65, 2067–2071.
[37] S. Sadegh-Samiei, I. Yavari, S. Skoulika, Helv. Chim. Acta 2015, 98, 589–
1963, 6, 1–9; b) D. Rosi, H. C. Neumann, R. G. Christiansen, H. P. Schane,
G. O. Potts, J. Med. Chem. 1977, 20, 349–352.
14] a) P. L. van der Peet, T. U. Connell, C. Gunawan, J. M. White, P. S. Donnelly,
S. J. Williams, J. Org. Chem. 2013, 78, 7298–7304; b) A. D. Burrows, C. G.
Frost, M. F. Mahon, P. R. Raithby, C. Richardson, A. J. Stevenson, Chem.
Commun. 2010, 46, 5064–5066; c) Y.-G. Lee, Y. Koyama, M. Yonekawa, T.
Takata, Macromolecules 2009, 42, 7709–7717.
15] For seminal reviews, see: a) A. Quilico, Isoxazoles and Related Compounds,
in: The Chemistry of Heterocyclic Compounds (Ed. A. Weissberger), Wiley,
New York, 1962, vol. 17, p. 1–233; b) Ch. Grundmann, P. Grünanger, The
Nitrile Oxides: Versatile Tools of Theoretical and Preparative Chemistry,
Springer, Berlin, 1971; c) P. Grünanger, P. Vita-Finzi, Isoxazoles, in: The
Chemistry of Heterocyclic Compounds (Eds.: E. C. Taylor, A. Weissberger),
Wiley, New York, 1991, vol. 49, part 1, p. 1–416; d) P. Grünanger, P. Vita-
Finzi, J. E. Dowling (Eds.), The Chemistry of Heterocyclic Compounds, Wiley,
New York, 1999, vol. 49, part 2.
16] For recent reviews, see: a) D. Giomi, F. M. Cordero, F. Machetti, Isoxazoles,
in: Comprehensive Heterocyclic Chemistry III (Ed.: A. R. Katritzky), Elsevier,
Oxford, UK, 2008, vol. 4, p. 365–486; b) A. M. S. Silva, A. C. Tome, T. M. V.
Pinho e Melo, J. Elguero, Five-Membered Heterocycles: 1,2-Azoles, part 2,
Isoxazoles and Isothiazoles, in: Modern Heterocyclic Chemistry (Eds.: J. Alva-
rez-Builla, J. J. Vaquero, J. Barluenga), Wiley-VCH, Weinheim, Germany,
5
92.
[
38] K.-i. Itoh, T. Aoyama, H. Satoh, Y. Fujii, H. Sakamaki, T. Takido, M. Kodo-
mari, Tetrahedron Lett. 2011, 52, 6892–6895.
[
[
[
[
39] L. Cecchi, F. De Sarlo, F. Machetti, Synlett 2007, 2451–2453.
40] L. Cecchi, F. De Sarlo, F. Machetti, Chem. Eur. J. 2008, 14, 7903–7912.
41] T. Gensch, F. Glorius, Science 2016, 352, 294–295.
42] a) E. Winterfeldt, Chem. Ber. 1964, 97, 1952–1958; b) R. M. Acheson, P. J.
Ansell, J. R. Murray, J. Chem. Res. Synop. 1986, 378–379; c) E. Wenkert,
K. A. H. Adams, C. L. Leicht, Can. J. Chem. 1963, 41, 1844–1846; d) M.
Medion-Simon, U. Pindur, Helv. Chim. Acta 1991, 74, 430–437.
43] We verified the dimerization of methyl propiolate in the presence of
DABCO or NMP; see the Exp. Section.
[
[
44] R. G. Pearson, D. H. Anderson, L. L. Alt, J. Am. Chem. Soc. 1955, 77, 527–
5
29.
[
[
[
45] S. Mo, P. Huang, J. Xu, Org. Biomol. Chem. 2014, 12, 4192–4200.
46] E. Trogu, L. Cecchi, F. De Sarlo, L. Guideri, F. Ponticelli, F. Machetti, Eur. J.
Org. Chem. 2009, 5971–5978.
[47] L. Cecchi, F. De Sarlo, C. Faggi, F. Machetti, Eur. J. Org. Chem. 2006, 3016–
3020.
2
011, p. 727–808; c) F. Hu, M. Szostak, Adv. Synth. Catal. 2015, 357, 2583–
[48] R. Zhang, J. Chen, Synthesis 1990, 817–819.
[49] See page 6894 in ref.[
38]
2614.
Eur. J. Org. Chem. 0000, 0–0
www.eurjoc.org
12
© 0000 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim